Human CDK4 Protein

CAT: 0952-B2011909Size: 100 µgDry Ice: NoHazardous: No
CAT#:0952-B2011909Size:100 µg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Human CDK4 Protein_x000D_ Catalog number: B2011909_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 100 µg_x000D_ Molecular Weight or Concentration: 36.1 kDa_x000D_ Supplied as: Solution_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: -20 °C_x000D_ Keywords: CMM3 protein, CDK4, CDK 4 protein, CDK 4, PSK-J3 protein, CDK-4, Cyclin-dependent kinase 4 protein, CDK-4 protein_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Braal CL, Jongbloed EM, Wilting SM, Mathijssen RHJ, Koolen SLW, Jager A. Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences Drugs. 2021 Feb;81(3):317-331._x000D_ 2: Gao X, Leone GW, Wang H. Cyclin D-CDK4/6 functions in cancer Adv Cancer Res. 2020;148:147-169._x000D_ 3: Goel S, DeCristo MJ, McAllister SS, Zhao JJ. CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest Trends Cell Biol. 2018 Nov;28(11):911-925._x000D_ 4: Suski JM, Braun M, Strmiska V, Sicinski P. Targeting cell-cycle machinery in cancer Cancer Cell. 2021 Jun 14;39(6):759-778._x000D_ 5: Pandey K, An HJ, Kim SK, Lee SA, Kim S, Lim SM, Kim GM, Sohn J, Moon YW. Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review Int J Cancer. 2019 Sep 1;145(5):1179-1188._x000D_ 6: Álvarez-Fernández M, Malumbres M. Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition Cancer Cell. 2020 Apr 13;37(4):514-529._x000D_ 7: Goel S, Bergholz JS, Zhao JJ. Targeting CDK4 and CDK6 in cancer Nat Rev Cancer. 2022 Jun;22(6):356-372._x000D_ 8: Ingham M, Schwartz GK. Cell-Cycle Therapeutics Come of Age J Clin Oncol. 2017 Sep 1;35(25):2949-2959._x000D_ 9: Yin Q, Jian Y, Xu M, Huang X, Wang N, Liu Z, Li Q, Li J, Zhou H, Xu L, Wang Y, Yang C. CDK4/6 regulate lysosome biogenesis through TFEB/TFE3 J Cell Biol. 2020 Aug 3;219(8):e201911036._x000D_ 10: Portman N, Alexandrou S, Carson E, Wang S, Lim E, Caldon CE. Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer Endocr Relat Cancer. 2019 Jan;26(1):R15-R30. _x000D_ _x000D_ Products Related to Human CDK4 Protein can be found at Proteins
Short Description
Catalog Number: B2011909 (100 µg)
Weight
0.15
Length
2
Width
0.5
Height
0.5

Related Products

CatalogName
B2018953Recombinant Human CDK4 & Cyclin D1 Protein (Full Length, GST Tag, Active)
B2022728Anti-Cyclin-Dependent Kinase 4 Cdk4 Antibody
B2011906Human CDK2 Protein
B2011908Human CDK3 Protein
B2011904Human CDK1 Protein
B2024089CDKL4 Protein-GST Fusion
B2023410Cdk2/Cyclin A Protein, Active
B2023416CDK5/p35 Protein, Active
B2024138CDK2 Protein-GST Fusion
B2023431Cdk5/p25 Protein, Active

Alternative Products

CatalogName
PROTP11802-500ugHuman CDK4 Recombinant Protein
ATGP1724-100Recombinant human CDK4 protein
OPCA00933-1MGCDK4 Recombinant Protein (Human)
MBS139197-01Human CDK4 Protein Lysate
UA080419-01CDK4/Cyclin D1 Protein, Human
P514260CDK4 Protein (N-His, Human)
P523230CDK4 Protein (N-GST, Human)
TP301156CDK4 (NM_000075) Human Recombinant Protein
KMPH2309Human CDK4 Protein, GST Tag
MF-0135520-01CDK4 Protein, Human, Recombinant (GST)

Popular Products